Are Synthetic Cannabinoids (K2 / Spice) legal in Austria?

Legal status

Not applicable as a class status, and not because the annexes are empty. Synthetic cannabinoids is an open ended market label rather than a substance: the source maps each named member individually and records that no claim is made that everything sold under this label is automatically covered. Nineteen members are named in Suchtgiftverordnung Annex IV.1. That annex carries JWH-018 and AM-2201, with UR-144 and XLR-11, plus AB-CHMINACA and AB-FUBINACA, together with AB-PINACA and ADB-BUTINACA, then ADB-FUBINACA and CUMYL-PeGACLONE, alongside 5F-PB-22 and 5F-AMB-PINACA, next 5F-APINACA and 4F-MDMB-BINACA, followed by 5F-MDMB-PICA and 5F-MDMB-PINACA, and finally FUB-AMB with MDMB-CHMICA and MDMB-4en-PINACA. Three more sit in Annex V.2, namely ADB-CHMINACA, CUMYL-4CN-BINACA and 4F-MDMB-BICA, while DMHP and parahexyl sit in Annex V.1, delta-9-THC in Annex IV.1, the enumerated other THC isomers in Annex V.1 and THCA in Annex V.2. Everything else is reached, if at all, through the twelve separately defined cores in Annex II group 1 of the NPS regulation: indol-3-yl methanone, indol-3-yl methane, pyrrol-3-yl methanone, the two stated indene cores, 2-(3-hydroxycyclohexyl)phenol, indole-3-carboxylic acid derivatives, indazole-3-carboxamide, indazol-3-yl methanone, phenyl-ethyl isoindolone, oxo-benzimidazolin-N-carboxamide, tetrahydrobenzo[c]chromen-1-ol and hexahydrobenzo[c]chromen-1-ol. Those cores are alternatives and not an all cannabinoids catch all, and HHC, CBN and THCP carry their own rows because the cores answer them differently. No single terminal status can honestly be stated for the label itself.

Consequences if caught

Capital exposure: none. The custodial ceiling is member specific rather than class wide. A member named in Suchtgiftverordnung Annex IV.1, V.1 or V.2 is a narcotic and can in principle reach life imprisonment under SMG §28a(5), which provides ten to twenty years or life for a person leading a larger connection of people in §28a(1) conduct. A member reached only through one of the twelve NPS cores tops out at ten years under NPSG §4(2), and its base offence in §4(1) carries two years and is a supply offence rather than a possession offence. A compound that fits neither carries no drug ceiling at all until an instrument reaches it. Because the SMG is applied first, a structural overlap does not produce liability under both regimes, and the identification of the actual molecule is what decides between a two year offence and a life ceiling. Separately from that, and carried forward from this site's published Austria entry rather than re-derived from the Suchtmittelgesetz in this pass, the published penalties are these. Austrian practice is depenalised and not legalised, and the published entry says so in those terms. There is no legal minimum quantity, and possession of any amount for personal use is punishable under section 27, up to six months in prison or a fine. Under Therapie statt Strafe at section 35, small quantity personal use is typically provisionally suspended from prosecution on one to two years of probation where the person accepts counselling or treatment. Consumption itself is not criminalised, but the possession that precedes it is. Above the Grenzmenge, the threshold quantity, the offence becomes dealing or trafficking under sections 28 and 28a, up to one to three years, escalating to ten to fifteen years for commercial or organised cases. Every figure in this paragraph is a penalty range or a fine and none of them is a quantity threshold. Whether the offence reaches this row at all is exactly what was not established, so they are recorded as Austria's published drug penalties and not as this row's exposure.

If prescribed or medical

Austria's traveller rule is SMG §5(1) and it cannot be applied to a market label, because the Act confines a named Suchtmittel to medical, dental, veterinary and scientific purposes and this heading names none. No synthetic cannabinoid in either list has an Austrian medicinal authorisation, so no dispensed product exists to be carried under any of them. NPSG §2 keeps lawful medicinal channels outside the NPS regime, which is a carve out for authorised products rather than a route for a traveller. Delta-9-THC is the one related entry with a genuine medicinal dimension, and it is answered on the narcotics side rather than here.

Documentation

Carry nothing under this heading, since the label designates no substance and no product sold under it holds an Austrian authorisation. Identify the actual compound before asking the question, because the same phrase spans nineteen named Annex IV.1 narcotics, three in Annex V.2 and an open structural family in the NPS annex. The narcotics entries were read at the 18 September 2026 consolidation whose last list amendment is BGBl II 180/2026, and the twelve cores at the structural annex last amended by BGBl II 106/2024.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Austria’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.